INT 0123 (Radiation Therapy Oncology Group 94 – 05) phase III trial of combined modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. - Minsky,B.D.; Pajak,T.F.; Ginsberg,R.J. (J Clin Oncol, 2002)